.
Name : Ms. RASHMI CHHABRA
Lab No. : 469612062 Age : 48 Years
Ref By : Dr. PRANAB PRADHAN Gender : Female
Collected : 5/4/2024 9:25:00AM Reported : 5/4/2024 5:02:47PM
A/c Status : P Report Status : Interim
Collected at : LPL - ASHOK VIHAR Processed at : LPL-NATIONAL REFERENCE LAB
B2/9,ANMOL HOUSE,NEAR SYNDICATE BANK, National Reference laboratory, Block E,
ASHOK VIHAR PHASE -2 NEW DELHI-110052. Sector 18, Rohini, New Delhi -110085
HOK VIHAR PHASE -2 NEW DELHI-110052
DELHI
Test Report
Test Name Results Units Bio. Ref. Interval
LIPID PROFILE, BASIC, SERUM
Cholesterol Total 185 mg/dL <200
(CHO-POD)
Triglycerides 123 mg/dL <150
(GPO-POD)
HDL Cholesterol 46 mg/dL >50
(Enz Immunoinhibition)
LDL Cholesterol,Direct 136 mg/dL <100
(Enz Selective protection)
VLDL Cholesterol 25 mg/dL <30
(Calculated)
Non-HDL Cholesterol 139 mg/dL <130
(Calculated)
Note
1. Measurements in the same patient can show physiological & analytical variations. Three serial
samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL & LDL Cholesterol.
2. Lipid Association of India (LAI) recommends screening of all adults above the age of 20 years for
Atherosclerotic Cardiovascular Disease (ASCVD) risk factors especially lipid profile. This should be
done earlier if there is family history of premature heart disease, dyslipidemia, obesity or other risk
factors
ASCVD Risk Stratification & Treatment goals in Indian population
1. Indians are at very high risk of developing ASCVD, they usually get the disease at an early age,
have a more severe form of the disease and have poorer outcome as compared to the western
populations
2. Many individuals remain asymptomatic before they get heart attack, ASCVD risk helps to identify
high risk individuals even when there is no symptom related to heart disease
3. ASCVD risk category helps clinician to decide when to consider therapy and what should be the
treatment goal
Treatment Goals as per Lipid Association of India 2020
*469612062* Page 1 of 7
.
Name : Ms. RASHMI CHHABRA
Lab No. : 469612062 Age : 48 Years
Ref By : Dr. PRANAB PRADHAN Gender : Female
Collected : 5/4/2024 9:25:00AM Reported : 5/4/2024 5:02:47PM
A/c Status : P Report Status : Interim
Collected at : LPL - ASHOK VIHAR Processed at : LPL-NATIONAL REFERENCE LAB
B2/9,ANMOL HOUSE,NEAR SYNDICATE BANK, National Reference laboratory, Block E,
ASHOK VIHAR PHASE -2 NEW DELHI-110052. Sector 18, Rohini, New Delhi -110085
HOK VIHAR PHASE -2 NEW DELHI-110052
DELHI
Test Report
Test Name Results Units Bio. Ref. Interval
--------------------------------------------------------------------------------------------
| | CONSIDER THERAPY | TREATMENT GOAL |
| ASCVD RISK |-------------------------------------|----------------------------------------|
| CATEGORY@ | LDL CHOLESTEROL| NON HDL CHLOESTEROL| LDL CHOLESTEROL | NON HDL CHLOESTEROL|
| | (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)| (LDL-C)(mg/dL) |(NON HDL-C) (mg/dL |
|--------------|----------------|--------------------|-------------------|--------------------|
|Extreme (A) | >=50 | >=80 |<50 (Indispensable)| <80 |
| | | |<30 (Optional) | |
|--------------|----------------|--------------------|-------------------|--------------------|
|Extreme (B) | >=30 | >=60 | <30 | <60 |
|--------------|----------------|--------------------|-------------------|--------------------|
| Very High | >=50 | >=80 | <50 | <80 |
|--------------|----------------|--------------------|-------------------|--------------------|
| High | >=70 | >=100 | <70 | <100 |
|--------------|----------------|--------------------|-------------------|--------------------|
| Moderate | >=100 | >=130 | <100 | <130 |
|--------------|----------------|--------------------|-------------------|--------------------|
| Low | >=130* | >=160* | <100 | <130 |
---------------------------------------------------------------------------------------------
* In low risk patient, consider therapy after an initial non-pharmacological intervention for at least 3 months
@To know your risk category click on bit.ly link sent on your registered mobile number, answer the
questionnaire, the ASCVD risk report can be downloaded from website
KIDNEY PANEL; KFT,SERUM
Creatinine 0.60 mg/dL 0.55 - 1.02
(Modified Jaffe,Kinetic)
GFR Estimated 110 mL/min/1.73m2 >59
(CKD EPI Equation 2021)
GFR Category G1
(KDIGO Guideline 2012)
Urea 19.30 mg/dL 13.00 - 43.00
(Urease UV)
Urea Nitrogen Blood 9.01 mg/dL 6.00 - 20.00
(Calculated)
BUN/Creatinine Ratio 15
(Calculated)
Uric Acid 3.70 mg/dL 2.60 - 6.00
(Uricase)
Total Protein 6.70 g/dL 5.70 - 8.20
(Biuret)
Albumin 4.29 g/dL 3.20 - 4.80
(BCG)
A : G Ratio 1.78 0.90 - 2.00
(Calculated)
*469612062* Page 2 of 7
.
Name : Ms. RASHMI CHHABRA
Lab No. : 469612062 Age : 48 Years
Ref By : Dr. PRANAB PRADHAN Gender : Female
Collected : 5/4/2024 9:25:00AM Reported : 5/4/2024 5:02:47PM
A/c Status : P Report Status : Interim
Collected at : LPL - ASHOK VIHAR Processed at : LPL-NATIONAL REFERENCE LAB
B2/9,ANMOL HOUSE,NEAR SYNDICATE BANK, National Reference laboratory, Block E,
ASHOK VIHAR PHASE -2 NEW DELHI-110052. Sector 18, Rohini, New Delhi -110085
HOK VIHAR PHASE -2 NEW DELHI-110052
DELHI
Test Report
Test Name Results Units Bio. Ref. Interval
Calcium, Total 9.40 mg/dL 8.70 - 10.40
(Arsenazo III)
Phosphorus 3.94 mg/dL 2.40 - 5.10
(Molybdate UV)
Sodium 141.00 mEq/L 136.00 - 145.00
(Indirect ISE)
Potassium 4.93 mEq/L 3.50 - 5.10
(Indirect ISE)
Chloride 106.00 mEq/L 98.00 - 107.00
(Indirect ISE)
Note
1. Estimated GFR (eGFR) calculated using the 2021 CKD-EPI creatinine equation and GFR Category
reported as per KDIGO guideline 2012.
2. eGFR category G1 or G2 does not fulfil the criteria for CKD, in the absence of evidence of kidney
damage
3. The BUN-to-creatinine ratio is used to differentiate prerenal and postrenal azotemia from renal
azotemia. Because of considerable variability, it should be used only as a rough guide. Normally, the
BUN/creatinine ratio is about 10:1
*469612062* Page 3 of 7
.
Name : Ms. RASHMI CHHABRA
Lab No. : 469612062 Age : 48 Years
Ref By : Dr. PRANAB PRADHAN Gender : Female
Collected : 5/4/2024 9:25:00AM Reported : 5/4/2024 5:02:59PM
A/c Status : P Report Status : Interim
Collected at : LPL - ASHOK VIHAR Processed at : LPL-NATIONAL REFERENCE LAB
B2/9,ANMOL HOUSE,NEAR SYNDICATE BANK, National Reference laboratory, Block E,
ASHOK VIHAR PHASE -2 NEW DELHI-110052. Sector 18, Rohini, New Delhi -110085
HOK VIHAR PHASE -2 NEW DELHI-110052
DELHI
Test Report
Test Name Results Units Bio. Ref. Interval
VITAMIN B12; CYANOCOBALAMIN, SERUM 242.00 pg/mL 211.00 - 911.00
(CLIA)
Notes
1. Interpretation of the result should be considered in relation to clinical circumstances.
2. It is recommended to consider supplementary testing with plasma Methylmalonic acid (MMA) or
plasma homocysteine levels to determine biochemical cobalamin deficiency in presence of clinical
suspicion of deficiency but indeterminate levels. Homocysteine levels are more sensitive but MMA is
more specific
3. False increase in Vitamin B12 levels may be observed in patients with intrinsic factor blocking
antibodies, MMA measurement should be considered in such patients
4. The concentration of Vitamin B12 obtained with different assay methods cannot be used
interchangeably due to differences in assay methods and reagent specificity
VITAMIN D, 25 - HYDROXY, SERUM 18.58 nmol/L 75.00 - 250.00
(CLIA)
Interpretation
-------------------------------------------------------------
| LEVEL | REFERENCE RANGE | COMMENTS |
| | IN nmol/L | |
|---------------|-----------------|---------------------------|
| Deficient | < 50 | High risk for developing |
| | | bone disease |
|---------------|-----------------|---------------------------|
| Insufficient | 50-74 | Vitamin D concentration |
| | | which normalizes |
| | | Parathyroid hormone |
| | | concentration |
|---------------|-----------------|---------------------------|
| Sufficient | 75-250 | Optimal concentration |
| | | for maximal health benefit|
|---------------|-----------------|---------------------------|
| Potential | >250 | High risk for toxic |
| intoxication | | effects |
-------------------------------------------------------------
Note
· The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D.
· 25 (OH)D is influenced by sunlight, latitude, skin pigmentation, sunscreen use and hepatic function.
· Optimal calcium absorption requires vitamin D 25 (OH) levels exceeding 75 nmol/L.
*469612062* Page 4 of 7
.
Name : Ms. RASHMI CHHABRA
Lab No. : 469612062 Age : 48 Years
Ref By : Dr. PRANAB PRADHAN Gender : Female
Collected : 5/4/2024 9:25:00AM Reported : 5/4/2024 5:02:59PM
A/c Status : P Report Status : Interim
Collected at : LPL - ASHOK VIHAR Processed at : LPL-NATIONAL REFERENCE LAB
B2/9,ANMOL HOUSE,NEAR SYNDICATE BANK, National Reference laboratory, Block E,
ASHOK VIHAR PHASE -2 NEW DELHI-110052. Sector 18, Rohini, New Delhi -110085
HOK VIHAR PHASE -2 NEW DELHI-110052
DELHI
Test Report
Test Name Results Units Bio. Ref. Interval
· It shows seasonal variation, with values being 40-50% lower in winter than in summer.
· Levels vary with age and are increased in pregnancy.
· A new test Vitamin D, Ultrasensitive by LC-MS/MS is also available
Comments
Vitamin D promotes absorption of calcium and phosphorus and mineralization of bones and teeth. Deficiency
in children causes Rickets and in adults leads to Osteomalacia. It can also lead to Hypocalcemia and
Tetany. Vitamin D status is best determined by measurement of 25 hydroxy vitamin D, as it is the major
circulating form and has longer half life (2-3 weeks) than 1,25 Dihydroxy vitamin D (5-8 hrs).
Decreased Levels
· Inadequate exposure to sunlight
· Dietary deficiency
· Vitamin D malabsorption
· Severe Hepatocellular disease
· Drugs like Anticonvulsants
· Nephrotic syndrome
Increased levels
Vitamin D intoxication
*469612062* Page 5 of 7
.
Name : Ms. RASHMI CHHABRA
Lab No. : 469612062 Age : 48 Years
Ref By : Dr. PRANAB PRADHAN Gender : Female
Collected : 5/4/2024 9:25:00AM Reported : 5/4/2024 5:03:10PM
A/c Status : P Report Status : Interim
Collected at : LPL - ASHOK VIHAR Processed at : LPL-NATIONAL REFERENCE LAB
B2/9,ANMOL HOUSE,NEAR SYNDICATE BANK, National Reference laboratory, Block E,
ASHOK VIHAR PHASE -2 NEW DELHI-110052. Sector 18, Rohini, New Delhi -110085
HOK VIHAR PHASE -2 NEW DELHI-110052
DELHI
Test Report
Test Name Results Units Bio. Ref. Interval
URINE EXAMINATION, ROUTINE; URINE, R/E
(Automated Strip Test, Microscopy)
Physical
Colour Light Yellow Pale yellow
Specific Gravity <=1.005 1.001 - 1.030
pH 8 5.0 - 8.0
Chemical
Proteins Negative Negative
Glucose Negative Negative
Ketones Negative Negative
Bilirubin Negative Negative
Urobilinogen Negative Negative
Leucocyte Esterase Negative Negative
Nitrite Negative Negative
Microscopy
R.B.C. Negative 0.0 - 2.0 RBC/hpf
Pus Cells Negative 0-5 WBC / hpf
Epithelial Cells 0-1 Epi Cells/hpf 0.0 - 5.0 Epi
cells/hpf
Casts None seen None seen/Lpf
Crystals None seen None seen
Others None seen None seen
*469612062*
Page 6 of 7
.
Name : Ms. RASHMI CHHABRA
Lab No. : 469612062 Age : 48 Years
Ref By : Dr. PRANAB PRADHAN Gender : Female
Collected : 5/4/2024 9:25:00AM Reported : 5/4/2024 5:03:10PM
A/c Status : P Report Status : Interim
Collected at : LPL - ASHOK VIHAR Processed at : LPL-NATIONAL REFERENCE LAB
B2/9,ANMOL HOUSE,NEAR SYNDICATE BANK, National Reference laboratory, Block E,
ASHOK VIHAR PHASE -2 NEW DELHI-110052. Sector 18, Rohini, New Delhi -110085
HOK VIHAR PHASE -2 NEW DELHI-110052
DELHI
Test Report
Test Name Results Units Bio. Ref. Interval
Dr Himangshu Mazumdar Dr.Kamal Modi Dr Nimmi Kansal Dr Shalabh Malik
MD, Biochemistry MD, Biochemistry MD, Biochemistry MD, Microbiology
Sr. Consultant Biochemist Consultant Biochemist Technical Director - Clinical Chemistry Technical Director - Microbiology,
NRL - Dr Lal PathLabs Ltd NRL - Dr Lal PathLabs Ltd & Biochemical Genetics Infectious Disease Molecular &
NRL - Dr Lal PathLabs Ltd Serology, Clinical Pathology
NRL - Dr Lal PathLabs Ltd
AHEEEHAPMKHIBLCNLKAMBLLCBILLJCECCLJCIKPLPKEDFJFAPPAHEEEHA
BNFFFNBPAPBCMHEGFGEGJOAPAOAHFHALBKJOBCJGFLEKMOJHNPBNFFFNB
CIEGAAFJLMMEGNBOPFIAAJHFJEBEHEDBLKPHENFLMLKIOEFLBKHDEHANP
DJEEIGFNBJKIEDIPCKOELFMFAFHKBLBFJIFFOBPAKCLJPDNLIDFBKEMEK
KCECLHFJONBFDIAFIOJCKPJDBENPMNCHKKMDAOMIPLKGKPNGKFFFOIMMH
OGCBBEFNNICGDIEKIHMPHIPBADHFOFAINDFCBKDKBLIKONNALNEJPOMCL
HLIMIJFFILOKPONIEKMKCGEHIHAFJBALPFGPBLMKOJCHKJFJAJNNIDILD
NJJJAMFMBKMCOAHJGANHDADILLBMFMBHMFCCAMNNIIKNOPNKBNFNBHILL
NKMMJDFLOLFGFAAPHOPIHAMKHONFEKFBJFFLBKPFOOBIOCNKDJPHNEKLJ
MOMIGDFCELNJJDCMIJPFGPNKKDFKPNJHKEPHEFNLNKCKIGEOCMGKHIGJK
AHIKOLFLGKCBMPDMPNJFMJEEINMGFMEBJNFEBFOEONDMKPFKEPCIGKAMG
ACICGJFCPLDOCICMHHGBKMCEIEOPPFOEBCFPBLNOOLJBIKNINKONHDICL
MNNNNNEHKFBCIKGJOCFLHICHJBAHFHAHNKPFCMNLMKJCLFNJAHFHAHIKL
APBBBPAPBGMAEJBPJNAKCJKFAFECHHCAONFFPLPGOLMHNLNNEDFDGBKHH
HHHHHHHPHHHPHPPPPHHPPPHHHHPPPPPPPPPHHPHPPHHHPHPHHHHHHHPHP
Result/s to follow:
HEMOGRAM, LIVER PANEL 1; LFT,SERUM, HIV 1 & 2 ANTIBODIES SCREENING TEST, SERUM, GLUCOSE,
FASTING (F), PLASMA, HEPATITIS B SURFACE ANTIGEN;HBsAg, SERUM, HEPATITIS C ANTIBODY (Anti-HCV),
SERUM
IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost
for derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe
Courts/Forum at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid
for medico legal purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical
Practitioner/Doctor. ŸThe report does not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: [email protected]
National Reference lab, Delhi, a CAP (7171001) Accredited, ISO 9001:2015 (FS60411) & ISO 27001:2013 (616691) Certified laboratory.
*469612062*
Page 7 of 7
